Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Review uri icon

Overview

abstract

  • Several recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.

publication date

  • March 1, 2011

Research

keywords

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Irritable Bowel Syndrome
  • Prebiotics
  • Probiotics
  • Synbiotics

Identity

Scopus Document Identifier

  • 79951570315

Digital Object Identifier (DOI)

  • 10.1016/j.gtc.2010.12.009

PubMed ID

  • 21333908

Additional Document Info

volume

  • 40

issue

  • 1